CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests
Balance at the beginning of the period (in shares) at Dec. 31, 2022				56,226,273
Balance at the beginning of the period at Dec. 31, 2022	$ 3,606,112		$ 3,540,499	$ 564	$ 3,972,561	$ 168,077	$ 10,335	$ (611,038)	$ 65,613
Balance at the beginning of the period (in shares) at Dec. 31, 2022								(6,424,276)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(22,627)		(22,745)			(22,745)			118
Interest rate swaps, net of tax	(5,330)	[1]	(5,330)				(5,330)
Teravalis noncontrolling interest	56								56
Stock plan activity (in shares)				201,655				(7,166)
Stock plan activity	4,334		4,334	$ 2	4,953			$ (621)
Other	(22)								(22)
Balance at the end of the period (in shares) at Mar. 31, 2023				56,427,928
Balance at the end of the period at Mar. 31, 2023	$ 3,582,523		3,516,758	$ 566	3,977,514	145,332	5,005	$ (611,659)	65,765
Balance at the end of the period (in shares) at Mar. 31, 2023								(6,431,442)
Balance at the beginning of the period (in shares) at Dec. 31, 2023	10			10
Balance at the beginning of the period at Dec. 31, 2023	$ 3,058,597		2,992,544	$ 0	3,374,284	(383,012)	1,272	$ 0	66,053
Balance at the beginning of the period (in shares) at Dec. 31, 2023								0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(51,905)		(51,915)			(51,915)			10
Interest rate swaps, net of tax	2,625	[1]	2,625				2,625
Teravalis noncontrolling interest	67								67
Capital transactions with HHH	$ 2,887		2,887		2,888	(1)
Balance at the end of the period (in shares) at Mar. 31, 2024	10			10
Balance at the end of the period at Mar. 31, 2024	$ 3,012,271		$ 2,946,141	$ 0	$ 3,377,172	$ (434,928)	$ 3,897	$ 0	$ 66,130
Balance at the end of the period (in shares) at Mar. 31, 2024								0

[1] Amounts are shown net of tax expense of $0.8 million for the three months ended March 31, 2024, and tax benefit of $1.6 million for the three months ended March 31, 2023.